Pharming Group N.V.
Develops and commercializes medicines for rare, debilitating, and life-threatening diseases.
PHARM | AS
Overview
Corporate Details
- ISIN(s):
- NL0010391025 (+1 more)
- LEI:
- 724500DCJ9MPG74JEH91
- Country:
- Netherlands
- Address:
- Darwinweg 24, 2333CR Leiden
- Website:
- https://www.pharming.com/
- Sector:
- Manufacturing
Description
Pharming Group N.V. is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company develops and commercializes an innovative portfolio of medicines to serve patients with unmet medical needs. Its portfolio includes protein replacement therapies, precision medicines, small molecules, and biologics.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2013-06-21 08:45 |
Pharming Confirms Completion Of Redemption Of Fourth Tranche Of Convertible Bond
|
English | 90.8 KB | ||
| 2013-06-18 14:18 |
Santarus And Pharming Announce FDA Acceptance For Review Of Ruconest (Recombina…
|
English | 245.8 KB | ||
| 2013-05-23 14:37 |
Pharming Announces New Data On Ruconest In Primate Model Of Delayed Graft Funct…
|
English | 94.8 KB | ||
| 2013-05-21 14:24 |
Pharming confirms completion of redemption of 3rd tranche and the redemption of…
|
English | 91.2 KB | ||
| 2013-05-21 08:53 | English | 377.2 KB | |||
| 2013-05-16 08:40 |
PHARMING REPORTS ON FINANCIAL RESULTS FIRST QUARTER 2013
|
English | 430.6 KB | ||
| 2013-04-17 08:16 |
Pharming redeems third tranche of convertible bond
|
English | 179.4 KB | ||
| 2013-04-17 08:14 |
Pharming and Santarus announce submission of Ruconest Biological License Applic…
|
English | 283.8 KB | ||
| 2013-04-12 08:45 |
Pharming confirms completion of redemption of second tranche of convertible bond
|
English | 180.7 KB | ||
| 2013-03-31 12:04 | English | 1.8 MB | |||
| 2013-03-28 08:23 |
Pharming announces EMA approval of new manufacturing site for Ruconest®
|
English | 180.3 KB | ||
| 2013-03-11 09:30 |
Pharming redeems second tranche of convertible bond
|
English | 85.9 KB | ||
| 2013-03-07 08:55 |
Pharming reports on preliminary financial results 2012
|
English | 220.2 KB | ||
| 2013-02-28 16:34 |
Pharming reports on Extraordinary General Meeting
|
English | 122.3 KB | ||
| 2013-01-16 07:44 |
Pharming announces €16.35 million convertible bond financing
|
English | 157.3 KB |
Automate Your Workflow. Get a real-time feed of all Pharming Group N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharming Group N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharming Group N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-05-24 | D.A. Jorn | Non-Executive member | Other | 7,446 | N/A |
| 2023-03-21 | P. Sekhri | Non-Executive member | Other | 9,363 | N/A |
| 2022-10-27 | P. Sekhri | Non-Executive member | Buy | 13,013 | 12,232.22 EUR |
| 2022-10-27 | M. Pykett | Non-Executive member | Buy | 9,760 | 9,174.40 EUR |
| 2022-08-04 | P. Sekhri | Non-Executive member | Buy | 13,013 | 10,000.23 EUR |
| 2022-08-04 | S. Baert | Non-Executive member | Buy | 9,760 | 7,500.36 EUR |
| 2022-05-25 | J. van der Meijs | Non-Executive member | Buy | 9,300 | 86,490,000.00 EUR |
| 2022-05-25 | P. Sekhri | Non-Executive member | Buy | 12,398 | 9,527.62 EUR |
| 2022-05-25 | M. Pykett | Non-Executive member | Buy | 9,300 | 7,146.86 EUR |
| 2022-03-24 | S. de Vries | Non-Executive member | Buy | 318,150 | 232,249.50 EUR |
Peer Companies
